0 Yorumlar
0 hisse senetleri
450 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Laryngeal Cancer Therapeutics Market: Global Pharmaceutical Companies, Oncology Treatment Solutions and Industry Growth Outlook"According to the latest report published by Data Bridge Market Research, the Laryngeal Cancer Therapeutics Market CAGR Value The global laryngeal cancer therapeutics market size was valued at USD 4.53 billion in 2025 and is expected to reach USD 6.44 billion by 2033, at a CAGR of 4.50% during the forecast period The Laryngeal Cancer Therapeutics Market analysis report...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Peptide Based Cancer Therapeutics Market Trends in Targeted OncologyValued at USD 8.58 billion in 2019, the peptide based cancer therapeutics market is projected to reach USD 17.18 billion by 2027, growing at a CAGR of 9.1% during the forecast period 2020–2027. Growth is attributed to innovations in peptide based cancer treatment approaches, the growing prevalence of different cancer types, high-efficacy peptide drugs, and rising pharmaceutical interest...0 Yorumlar 0 hisse senetleri 109 Views 0 önizleme
-
The Future of Cancer Care: How Oncology Therapeutics Are Advancing Patient OutcomesOncology therapeutics have revolutionized cancer care, offering patients a growing arsenal of innovative treatments that are more effective, better tolerated, and more personalized than ever before. From targeted therapies and immunotherapies to novel drug conjugates and gene therapies, these treatments are transforming the way cancer is managed and improving outcomes for patients worldwide....0 Yorumlar 0 hisse senetleri 595 Views 0 önizleme
-
Daratumumab Injection Market: Competitive Landscape, Strategic Collaborations, and the Rise of Subcutaneous FormulationsThe Daratumumab Injection Market is a dynamic and highly competitive sector characterized by intense research and development activities, strategic collaborations, and a relentless pursuit of innovation. As the market is projected to reach USD 7.0 billion by 2035, growing at a CAGR of 10.1%, key players are actively seeking to differentiate themselves through advanced product...0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Yorumlar 0 hisse senetleri 500 Views 0 önizleme
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek